XERS – xeris biopharma holdings, inc. (US:NASDAQ)
Stock Stats
News
Is It Too Late To Consider Xeris Biopharma Holdings (XERS) After Its 133% One-Year Surge? [Yahoo! Finance]
Assessing Xeris Biopharma Holdings (XERS) Valuation After Strong Recent Shareholder Returns [Yahoo! Finance]
Why Xeris Biopharma Holdings (XERS) Is Up 7.9% After Raising 2025 Revenue Outlook and Adding Patents [Yahoo! Finance]
Xeris Biopharma (NASDAQ:XERS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Xeris Expects to Deliver Record Fourth Quarter and Full-Year 2025 Total Revenue [Yahoo! Finance]
Form 4 Xeris Biopharma Holdings For: Jan 08 Filed by: McCulloch Kevin
Form 144 Xeris Biopharma Holdings Filed by: McCulloch Kevin
Form 8-K Xeris Biopharma Holdings For: Jan 08
Form 4 Xeris Biopharma Holdings For: Jan 05 Filed by: Shannon John Patrick Jr
Form 4 Xeris Biopharma Holdings For: Jan 02 Filed by: Hecht Beth
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.